Spire to develop glaucoma laser and plague test
This article was originally published in Clinica
In order to fulfil a need for a particular type of glaucoma treatment, Spire has received a $124,500 grant from the US National Eye Institute (of the National Institutes of Health) to develop a new surgical laser. According to Spire, there is currently no ideal laser for performing guarded sclerectomies. This involves piercing a tiny hole in the sclera in order to relieve pressure in the eye. The size of the hole is critical, so the laser needs to be very precise.